Literature DB >> 26333075

Losartan therapy for cardiac disease in paediatricMarfan syndrome.

Lisa J Ewans1, Phillip Roberts2, Lesley Adès1.   

Abstract

A case of severe early-onset Marfan syndrome (MFS) led us to ask the question: 'Should an ARB, particularly losartan [intervention], compared with beta blockade alone [comparison], be commenced in all paediatric MFS patients [patient] with aortic root dilatation [outcome]?' The current literature was critically appraised to address this question.
© 2015 The Authors. Journal of Paediatrics and Child Health © 2015 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  cardiology; genetics; pharmacology

Mesh：

Substances：

Year:  2015        PMID： 26333075     DOI： 10.1111/jpc.12823

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN： 1034-4810            Impact factor:   1.954


  1 in total

1.  Severe aortic root dilatation in infantile Marfan syndrome.

Authors:  Renita A Thomas; Chikamuche T Anyanwu; Maria Blazo; Saradha Subramanian
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.